These include inadequate glycemic control with other treatment options, marked variability in glucose on a day-to-day basis, a history of hyperglycemia unawareness, a need for flexibility in lifestyle, pregnancy, insulin sensitivity and low insulin requirements [14]. This evidence concerns the gene INS and Hyperglycemia.